D68.31 - Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
The ICD 10 Code for Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors is listed as D68.31.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field | Value |
|---|---|
| Diagnosis Code: | D68.31
|
| Description: | Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| Chapter | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
| Block | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
| Parent | D68.3 - Hemorrhagic disorder due to circulating anticoagulants |
| ICD-10-CM Children (deeper level / typically more specific) of D68.31: | |
| D68.311 - Acquired hemophilia | |
| D68.312 - Antiphospholipid antibody with hemorrhagic disorder | |
| D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors | |
| ICD-10-CM Siblings (same level / similar specificity) of D68.31: | |
| D68.32 - Hemorrhagic disorder due to extrinsic circulating anticoagulants | |